title: NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
abstract: NK cells are regulated by inhibiting and activating cell surface receptors. Most inhibitory receptors recognize MHC class I Ags and protect healthy cells from NK cell-mediated autoaggression. However, certain activating receptors, including the human activating killer cell Ig-like receptor (KIR) 2DS1, also recognize MHC class I. This fact raises the question of how NK cells expressing such activating receptors are tolerized to host tissues. We investigated whether the presence of HLA-C2, the cognate ligand for 2DS1, induces tolerance in 2DS1-expressing NK cells. Anti-HLA-C2 activity could be detected in vitro in some 2DS1 positive NK clones irrespective of the presence or absence of HLA-C2 ligand in the donor. The frequency of anti-HLA-C2 reactivity was high in donors homozygous for HLA-C1. Surprisingly, no significant difference was seen in the frequency of anti-HLA-C2 cytotoxicity in donors heterozygous for HLA-C2 and donors without HLA-C2 ligand. However, donors homozygous for HLA-C2, compared with all other donors, had significantly reduced frequency of anti-HLA-C2 reactive clones. The 2DS1 positive clones that express inhibitory KIR for self-HLA class I were commonly noncytotoxic, and anti-HLA-C2 cytotoxicity was nearly exclusively restricted to 2DS1 single positive clones lacking inhibitory KIR. 2DS1 single positive NK clones with anti-HLA-C2 reactivity were also present posttransplantation in HLA-C2 positive recipients of hematopoietic stem cell transplants from 2DS1 positive donors. These results demonstrate that many NK cells with anti-HLA-C2 reactivity are present in HLA-C1 homozygous and heterozygous donors with 2DS1. In contrast, 2DS1 positive clones from HLA-C2 homozygous donors are frequently tolerant to HLA-C2.
authors.affiliation: Immunology Program, Sloan-Kettering Institute for Cancer Research, New York, NY 10065, USA.
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Pittari
authors.forename: Xiao-Rong
authors.initials: XR
authors.lastname: Liu
authors.forename: Annamalai
authors.initials: A
authors.lastname: Selvakumar
authors.forename: Zeguo
authors.initials: Z
authors.lastname: Zhao
authors.forename: Ernesto
authors.initials: E
authors.lastname: Merino
authors.forename: Morgan
authors.initials: M
authors.lastname: Huse
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Chewning
authors.forename: Katharine C
authors.initials: KC
authors.lastname: Hsu
authors.forename: Bo
authors.initials: B
authors.lastname: Dupont
mesh_terms: D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism; D015536:Down-Regulation / Q000276:immunology; D015236:HLA-C Antigens / Q000276:immunology* / Q000378:metabolism; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D019409:Interleukin-15 / Q000276:immunology / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D000075362:Leukocyte Immunoglobulin-like Receptor B1; D008024:Ligands; D011971:Receptors, Immunologic / Q000276:immunology / Q000378:metabolism; D054340:Receptors, KIR / Q000276:immunology* / Q000378:metabolism*; D014019:Tissue Donors
chemical_list: D015703:Antigens, CD; D015236:HLA-C Antigens; D019409:Interleukin-15; C496212:KIR2DS1 protein, human; C105299:LILRB1 protein, human; D000075362:Leukocyte Immunoglobulin-like Receptor B1; D008024:Ligands; D011971:Receptors, Immunologic; D054340:Receptors, KIR
references.citation: J Immunol. 1999 Aug 15;163(4):1859-67
references.pmid: 10438920
references.citation: Immunity. 1999 Jul;11(1):67-77
references.pmid: 10435580
references.citation: Nat Immunol. 2005 Sep;6(9):938-45
references.pmid: 16086018
references.citation: J Immunol. 1998 Apr 1;160(7):3096-100
references.pmid: 9531263
references.citation: J Exp Med. 1997 Dec 1;186(11):1809-18
references.pmid: 9382880
references.citation: Nat Immunol. 2007 Aug;8(8):856-63
references.pmid: 17618288
references.citation: Blood. 2007 Jul 15;110(2):578-86
references.pmid: 17392508
references.citation: J Immunol. 2003 Jun 1;170(11):5398-405
references.pmid: 12759414
references.citation: Nature. 1986 Feb 20-26;319(6055):675-8
references.pmid: 3951539
references.citation: J Exp Med. 2007 Nov 26;204(12):3027-36
references.pmid: 18025129
references.citation: J Immunol. 2006 Apr 15;176(8):5108-16
references.pmid: 16585609
references.citation: Nat Med. 1996 May;2(5):561-6
references.pmid: 8616716
references.citation: J Exp Med. 2008 Aug 4;205(8):1819-28
references.pmid: 18606858
references.citation: Nat Genet. 2007 Sep;39(9):1114-9
references.pmid: 17694058
references.citation: J Exp Med. 2010 Sep 27;207(10):2065-72
references.pmid: 20819928
references.citation: Clin Immunol. 2010 Apr;135(1):26-32
references.pmid: 20093094
references.citation: Immunity. 2002 Nov;17(5):537-47
references.pmid: 12433361
references.citation: Nature. 1998 Feb 19;391(6669):795-9
references.pmid: 9486650
references.citation: Blood. 2010 Dec 9;116(24):5208-16
references.pmid: 20736452
references.citation: Blood. 2009 Mar 26;113(13):3119-29
references.pmid: 18945967
references.citation: Nat Rev Immunol. 2005 Oct;5(10):772-82
references.pmid: 16200080
references.citation: Immunol Today. 1990 Jul;11(7):237-44
references.pmid: 2201309
references.citation: J Exp Med. 2010 Sep 27;207(10):2073-9
references.pmid: 20819924
references.citation: J Exp Med. 1994 Aug 1;180(2):687-92
references.pmid: 8046342
references.citation: Nature. 2005 Aug 4;436(7051):709-13
references.pmid: 16079848
references.citation: J Immunol. 1997 Dec 1;159(11):5192-6
references.pmid: 9548455
references.citation: Nature. 1992 Jul 2;358(6381):66-70
references.pmid: 1614533
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204
references.pmid: 9560253
references.citation: Nat Immunol. 2004 Mar;5(3):328-36
references.pmid: 14973437
references.citation: N Engl J Med. 2012 Aug 30;367(9):805-16
references.pmid: 22931314
references.citation: Sci Signal. 2011 Apr 05;4(167):ra21
references.pmid: 21467299
references.citation: Science. 2003 Sep 5;301(5638):1374-7
references.pmid: 12920303
references.citation: J Immunol. 2007 Jul 15;179(2):854-68
references.pmid: 17617576
references.citation: J Immunol. 2004 Sep 15;173(6):3594-8
references.pmid: 15356102
references.citation: Science. 2002 Mar 15;295(5562):2097-100
references.pmid: 11896281
references.citation: Eur J Immunol. 2007 Mar;37(3):780-7
references.pmid: 17301953
references.citation: J Immunol. 2002 Nov 1;169(9):5118-29
references.pmid: 12391228
references.citation: Int Immunol. 2008 Apr;20(4):555-63
references.pmid: 18308713
references.citation: Int Immunol. 1999 Jan;11(1):29-35
references.pmid: 10050671
references.citation: Immunity. 1997 Dec;7(6):753-63
references.pmid: 9430221
references.citation: Nat Immunol. 2005 Sep;6(9):928-37
references.pmid: 16116470
references.citation: Eur J Immunol. 1997 Dec;27(12):3095-9
references.pmid: 9464792
references.citation: J Exp Med. 2004 Oct 4;200(7):825-34
references.pmid: 15452177
references.citation: J Immunol. 2005 Jul 15;175(2):720-9
references.pmid: 16002667
references.citation: Immunity. 2006 Aug;25(2):331-42
references.pmid: 16901727
references.citation: J Exp Med. 2008 Aug 4;205(8):1829-41
references.pmid: 18606857
references.citation: Immunol Rev. 2006 Dec;214:186-201
references.pmid: 17100885
references.citation: Blood. 2011 Apr 21;117(16):4284-92
references.pmid: 21355085
references.citation: Blood. 2010 Feb 11;115(6):1166-74
references.pmid: 19903900
references.citation: Blood. 2005 Jun 15;105(12):4878-84
references.pmid: 15731175
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13224-9
references.pmid: 16141329
references.citation: J Cell Biol. 2011 Feb 21;192(4):675-90
references.pmid: 21339333